Patent classifications
C08F290/08
Bio-based superabsorbents prepared via the macromonomer approach
A novel bio-based superabsorbent polymer material based on a proteinaceous natural polymer is introduced herein. There is further disclosed a method for the manufacture of such a bio-based crosslinked superabsorbent polymer material. The method includes, but not limited to, introducing polymerizable unsaturated groups onto the natural polymer or its derivative so as to yield a macromonomer. The macromonomer can be formed by covalently binding unsaturated carbon-carbon double bonds to a proteinaceous substrate through a reaction of a selected chemical compound and the amino group on the proteinaceous substrate. The macromonomer is then copolymerized with unsaturated co-monomer(s) to form a crosslinked superabsorbent material.
Curable Composition, Temporary Bonding Material, and Method for Temporarily Bonding Component Part and Substrate By Same
A first curable composition has flowability and include a photopolymerizable group-containing silicone compound (A), a photopolymerization initiator, a photoacid generator and at least one kind of metal compound selected from the group consisting of metal carbonates, metal hydroxides and metal oxides. This curable composition provides a temporary bonding material capable of easily temporarily bonding a component part and a substrate, without trapping an air bubble in a temporary bonding surface of the component, and allowing easy separation of the component part and the substrate after performing various processing on the component part.
BIO-BASED SUPERABSORBENTS PREPARED VIA THE MACROMONOMER APPROACH
A novel bio-based superabsorbent polymer material based on a proteinaceous natural polymer is introduced herein. There is further disclosed a method for the manufacture of such a bio-based crosslinked superabsorbent polymer material. The method includes, but not limited to, introducing polymerizable unsaturated groups onto the natural polymer or its derivative so as to yield a macromonomer. The macromonomer can be formed by covalently binding unsaturated carbon-carbon double bonds to a proteinaceous substrate through a reaction of a selected chemical compound and the amino group on the proteinaceous substrate. The macromonomer is then copolymerized with unsaturated co-monomer(s) to form a crosslinked superabsorbent material.
BIO-BASED SUPERABSORBENTS PREPARED VIA THE MACROMONOMER APPROACH
A novel bio-based superabsorbent polymer material based on a proteinaceous natural polymer is introduced herein. There is further disclosed a method for the manufacture of such a bio-based crosslinked superabsorbent polymer material. The method includes, but not limited to, introducing polymerizable unsaturated groups onto the natural polymer or its derivative so as to yield a macromonomer. The macromonomer can be formed by covalently binding unsaturated carbon-carbon double bonds to a proteinaceous substrate through a reaction of a selected chemical compound and the amino group on the proteinaceous substrate. The macromonomer is then copolymerized with unsaturated co-monomer(s) to form a crosslinked superabsorbent material.
Phosphorylcholine group-containing polysiloxane monomer
The phosphorylcholine group-containing polysiloxane monomer of the present invention is represented by the formula (1). In the formula, a represents an integer of 20 to 500, b represents an integer of 1 to 70, c represents an integer of 1 to 70, d represents 0 or 1, p and q each represent 0 or 1, X represents CH.sub.2 or CH.sub.2CH.sub.2, and R represents an alkyl group having 2 to 18 carbon atoms. The present invention provides the phosphorylcholine group-containing polysiloxane monomer which gives, when copolymerized with a polymerizable monomer such as methacrylic acid or a hydrophilic monomer other than methacrylic acid, a polymer that exhibits surface hydrophilicity and sufficient stability as ophthalmic devices.
Phosphorylcholine group-containing polysiloxane monomer
The phosphorylcholine group-containing polysiloxane monomer of the present invention is represented by the formula (1). In the formula, a represents an integer of 20 to 500, b represents an integer of 1 to 70, c represents an integer of 1 to 70, d represents 0 or 1, p and q each represent 0 or 1, X represents CH.sub.2 or CH.sub.2CH.sub.2, and R represents an alkyl group having 2 to 18 carbon atoms. The present invention provides the phosphorylcholine group-containing polysiloxane monomer which gives, when copolymerized with a polymerizable monomer such as methacrylic acid or a hydrophilic monomer other than methacrylic acid, a polymer that exhibits surface hydrophilicity and sufficient stability as ophthalmic devices.
Composition for forming underlayer film for imprinting, method for producing composition for forming underlayer film, kit, pattern producing method, and method for manufacturing semiconductor element
Provided are: a composition for forming an underlayer film for imprinting, which contains a high-molecular-weight compound having a polymerizable group, a chelating agent, and a solvent, and a method for producing the same; a kit including the composition for forming an underlayer film; a pattern producing method using the composition for forming an underlayer film; and a method for manufacturing a semiconductor element, which includes the pattern producing method as a step.
ANTIVIRAL OPTICAL FILM, IMAGE DISPLAY PANEL, AND IMAGE DISPLAY DEVICE
Provided is an optical film which can have favorable antiviral properties while suppressing deterioration of visibility. An antiviral optical film, including a resin layer containing a binder resin and an antiviral agent on at least one surface, wherein a surface of the resin layer has a developed interfacial area ratio Sdr specified in ISO 25178-2:2012 of 1.010.sup.5 or more and 1.510.sup.1 or less.
ANTIVIRAL OPTICAL FILM, IMAGE DISPLAY PANEL, AND IMAGE DISPLAY DEVICE
Provided is an optical film which can have favorable antiviral properties while suppressing deterioration of visibility. An antiviral optical film, including a resin layer containing a binder resin and an antiviral agent on at least one surface, wherein a surface of the resin layer has a developed interfacial area ratio Sdr specified in ISO 25178-2:2012 of 1.010.sup.5 or more and 1.510.sup.1 or less.